Resolution for winding up (MVL)
Verso Biosense R&D Limited enters members' voluntary liquidation
In short: Verso Biosense R&D Limited (company no. 09890252) entered members' voluntary liquidation, a solvent and planned closure, according to a Resolution for winding up (MVL) notice published in The London Gazette on 28 September 2026. The office holders are Nicola Kate Clark; Andrew John Duncan, appointed 23 September 2026.
The notice announces that VERSO BIOSENSE R&D LIMITED resolved to be voluntarily wound up and appointed Nicola Kate Clark and Andrew John Duncan as joint liquidators at a general meeting on 23 September 2026.
Notice details
- Company
- VERSO BIOSENSE R&D LIMITED
- Company number
- 09890252
- Registered office
- MHA Advisory Ltd, 6th Floor, 2 London Wall Place, London, EC2Y 5AU (Formerly) 115b Innovation Drive, Milton Park, Milton, Abingdon, Oxfordshire, OX14 4RZ
- Principal trading address
- N/A
- Type of liquidation
- Voluntary winding up
- Office holder(s)/Liquidator(s)
- Nicola Kate Clark; Andrew John Duncan
- Office holder number(s)
- IP No. 19390; IP No. 9319
- Date of appointment
- 23 September 2026
- Appointed by
- General Meeting (special and ordinary resolution)
- Contact
- Fahad Mohammed, Email: [email protected], Tel: 020 8146 2375
What this notice means
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Read more: What is Liquidation?.
All notices for Verso Biosense R&D Limited
3 Gazette notices on record for company no. 09890252, newest first. The full history, with last filed accounts, is on the Verso Biosense R&D Limited company record.
- Notices to creditors (MVL) 28 Sep 2026
- Appointment of liquidators (MVL) 28 Sep 2026
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If VERSO BIOSENSE R&D LIMITED owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2 has backed and restructured UK businesses since 1990, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at VERSO BIOSENSE R&D LIMITED or something similar, start the conversation early.
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2 has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Frequently asked questions
Is Verso Biosense R&D Limited in financial difficulty?
No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Resolution for winding up (MVL) for Verso Biosense R&D Limited (company no. 09890252) on 28 September 2026.
What does a Resolution for winding up (MVL) mean?
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Who is dealing with the liquidation?
The office holders named in the notice: Nicola Kate Clark; Andrew John Duncan, appointed 23 September 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.